Cardiac Biomarkers (Online CE Course)

(based on 890 customer ratings)

Author: Mary Ellen Koenn, MS, MLS(ASCP)
Reviewer: Kevin F. Foley, PhD, DABCC, MT, SC

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 173 CE courses, most popular
$95Add to cart
Pick Your Courses
Up to 8 CE hours
$50Add to cart
Individual course$20Add to cart
Need multiple seats for your university or lab? Get a quote

Each year in the US alone, over one million individuals are diagnosed with an acute myocardial infarction (AMI) and approximately one half of these have had an AMI in the past. However, as many as 1 - 5% of patients with an AMI are misdiagnosed in the emergency department and are discharged. Rapid diagnosis of acute myocardial infarction is vital and laboratory testing that is sensitive and specific is essential. Upon completion of this course, you will be able to identify the characteristics of an optimal cardiac biomarker and discuss the laboratory tests that are most useful for rapid diagnosis and monitoring of ischemic heart disease and heart failure.

See all available courses

Continuing Education Credits

P.A.C.E.® Contact Hours (acceptable for AMT, ASCP, and state recertification): 1.5 hour(s)
Approved through 3/31/2024
Florida Board of Clinical Laboratory Personnel Credit Hours - General (Clinical Chemistry/UA/Toxicology): 1.5 hour(s)
Approved through 3/31/2024

Objectives

  • Describe the role of cardiac biomarkers, the characteristics of a good marker of cardiac disease, and the use of cardiac biomarkers today.
  • Explain atherosclerosis as an inflammatory process.
  • Compare and contrast the cardiac biomarkers cTnI and cTnT.
  • Discuss the utilization of CK-MB, myoglobin, and CK-isoform measurement in diagnosis of an acute myocardial infarction.
  • Describe the formation of BNP and NT-ProBNP and their role as markers of congestive heart failure.
  • Interpret the measurement results of cardiac biomarker assays in the diagnosis of an acute myocardial infarction and congestive heart failure.
  • Explain the role of cardiac biomarkers in risk stratification of those with heart disease.

Customer Ratings

(based on 890 customer ratings)

Course Outline

Click on the links below to preview selected pages from this course.
  • Cardiac and Vascular Disease
      • Introduction
      • Organizations and Agencies
      • The Human Heart
      • Which heart chamber pumps oxygenated blood out to the body?
      • Terminology Describing Ischemic Heart Disease and Heart Failure
      • Acute Coronary Syndrome
      • Risk Factors for Heart Disease
      • Ischemia refers to necrotic tissue caused by an infarcted blood supply.
      • Congestive heart failure (CHF) ordinarily results when the left ventricular myocardium is weakened.
      • Atherosclerosis
      • Fibrous Cap
      • Lipids
      • Monitoring Lipids
      • A buildup of plaque that occurs with atherosclerosis may eventually lead to which of the following events?
  • Biomarkers of Cardiac Disease
  • Biomarkers of An AMI
  • Biomarkers in CHF
      • Cardiac Biomarkers and Congestive Heart Failure (CHF)
      • Function of BNP
      • BNP Versus NT-ProBNP
      • BNP Versus NT-proBNP, continued
      • BNP and NT-ProBNP Measurement and Ranges
      • What is the function of the hormone, BNP?
      • A 79-year-old diabetic and retired homemaker lives alone since the death of her husband 5 years ago. At age 75, she was diagnosed with an AMI and had ...
  • Risk Stratification and Cardiac Biomarkers
  • Biomarkers to Identify Those at Risk for Developing Cardiac Disease
  • References
      • References

Additional Information

Level of instruction: Intermediate

Intended Audience: Clinical laboratory technologists and technicians, and other health care personnel who have an interest in this subject matter. This course is also appropriate for medical laboratory science students and pathology residents.
 
Author information: Mary Ellen Koenn, MS, MLS(ASCP) is an associate professor emeritus, West Virginia University School of Medicine, Medical Laboratory Science Program. During her career as a medical technologist and educator, she has been a laboratory supervisor and manager and has held several teaching positions. She is the author of numerous articles for laboratory publications and textbook chapters and is a frequent presenter at laboratory seminars and workshops. Ms. Koenn holds a Master of Science degree in Medical Technology.
 
Reviewer information: Kevin F. Foley, PhD, DABCC, MT, SC is the Northwest chemistry, toxicology, immunology and POC director for Kaiser Permanente. He also teaches pharmacology, clinical chemistry, immunology and medicinal chemistry at Oregon Health Sciences University. Dr. Foley earned his PhD in clinical pharmacology and toxicology at East Carolina School of Medicine in North Carolina. His research areas include cardiovascular risk and inflammation markers as well as the neuropharmacology of amphetamine-like compounds. He is a frequent contributor to several clinical laboratory publications and is active in the American Association of Clinical Chemistry.

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 173 CE courses, most popular
$95Add to cart
Pick Your Courses
Up to 8 CE hours
$50Add to cart
Individual course$20Add to cart
Need multiple seats for your university or lab? Get a quote
cardiac_marker_graph2


fibrous_cap


heart_diagram